157 related articles for article (PubMed ID: 28073181)
1. Participation restrictions in ambulatory amyotrophic lateral sclerosis patients: Physical and psychological factors.
Van Groenestijn AC; Schröder CD; Kruitwagen-Van Reenen ET; Van Den Berg LH; Visser-Meily JMA
Muscle Nerve; 2017 Nov; 56(5):912-918. PubMed ID: 28073181
[TBL] [Abstract][Full Text] [Related]
2. Predictors of health-related quality of life in people with amyotrophic lateral sclerosis.
Sandstedt P; Johansson S; Ytterberg C; Ingre C; Holmqvist LW; Kierkegaard M
J Neurol Sci; 2016 Nov; 370():269-273. PubMed ID: 27772773
[TBL] [Abstract][Full Text] [Related]
3. Relationship of the Tufts Quantitative Neuromuscular Exam (TQNE) and the Sickness Impact Profile (SIP) in measuring progression of ALS. SSNJV/CNTF ALS Study Group.
McGuire D; Garrison L; Armon C; Barohn R; Bryan W; Miller R; Parry G; Petajan J; Ross M
Neurology; 1996 May; 46(5):1442-4. PubMed ID: 8628496
[TBL] [Abstract][Full Text] [Related]
4. Participation and autonomy in the first 10 months after diagnosis of ALS: a longitudinal study.
Kruitwagen-Van Reenen ET; Scholten EWM; van Groenestijn A; Van Den Berg LH; Post MWM; Visser-Meily J
Amyotroph Lateral Scler Frontotemporal Degener; 2021 Nov; 22(7-8):459-466. PubMed ID: 33683160
[No Abstract] [Full Text] [Related]
5. Measurement of health-related quality of life in patients with amyotrophic lateral sclerosis in clinical trials of new therapies.
Damiano AM; Patrick DL; Guzman GI; Gawel MJ; Gelinas DF; Natter HM; Ingalls KK
Med Care; 1999 Jan; 37(1):15-26. PubMed ID: 10413388
[TBL] [Abstract][Full Text] [Related]
6. Usability of eyetracking computer systems and impact on psychological wellbeing in patients with advanced amyotrophic lateral sclerosis.
Linse K; Rüger W; Joos M; Schmitz-Peiffer H; Storch A; Hermann A
Amyotroph Lateral Scler Frontotemporal Degener; 2018 May; 19(3-4):212-219. PubMed ID: 29092645
[TBL] [Abstract][Full Text] [Related]
7. The functional and psychological status of patients with amyotrophic lateral sclerosis: some implications for rehabilitation.
Hunter MD; Robinson IC; Neilson S
Disabil Rehabil; 1993; 15(3):119-26. PubMed ID: 8374156
[TBL] [Abstract][Full Text] [Related]
8. Individual quality of life is not correlated with health-related quality of life or physical function in patients with amyotrophic lateral sclerosis.
Neudert C; Wasner M; Borasio GD
J Palliat Med; 2004 Aug; 7(4):551-7. PubMed ID: 15353099
[TBL] [Abstract][Full Text] [Related]
9. Multidisciplinary ALS care improves quality of life in patients with ALS.
Van den Berg JP; Kalmijn S; Lindeman E; Veldink JH; de Visser M; Van der Graaff MM; Wokke JH; Van den Berg LH
Neurology; 2005 Oct; 65(8):1264-7. PubMed ID: 16247055
[TBL] [Abstract][Full Text] [Related]
10. Disability and Contextual Factors in Patients with Amyotrophic Lateral Sclerosis - A Three-Year Observational Study.
Sandstedt P; Littorin S; Johansson S; Gottberg K; Ytterberg C; Kierkegaard M
J Neuromuscul Dis; 2018; 5(4):439-449. PubMed ID: 30282373
[TBL] [Abstract][Full Text] [Related]
11. The impact of physical impairment on emotional well-being in ALS.
Abdulla S; Vielhaber S; Kollewe K; Machts J; Heinze HJ; Dengler R; Petri S
Amyotroph Lateral Scler Frontotemporal Degener; 2014 Sep; 15(5-6):392-7. PubMed ID: 25008979
[TBL] [Abstract][Full Text] [Related]
12. Associations between illness cognitions and health-related quality of life in the first year after diagnosis of amyotrophic lateral sclerosis.
Kruitwagen-van Reenen ETH; Post MWM; van Groenestijn A; van den Berg LH; Visser-Meily JMA
J Psychosom Res; 2020 May; 132():109974. PubMed ID: 32155469
[TBL] [Abstract][Full Text] [Related]
13. Spanish adaptation of the Amyotrophic Lateral Sclerosis Questionnaire ALSAQ-40 for ALS patients.
Salas T; Mora J; Esteban J; Rodríguez F; Díaz-Lobato S; Fajardo M
Amyotroph Lateral Scler; 2008 Jun; 9(3):168-72. PubMed ID: 18574761
[TBL] [Abstract][Full Text] [Related]
14. Relationship between Pain and Functional Status in Patients with Amyotrophic Lateral Sclerosis: A Multicenter Cross-Sectional Study.
Ishida N; Hongo S; Kumano A; Hatta H; Zakoji N; Hirutani M; Yamamoto Y; Aono H; Tuigi M; Suzuki R; Hanamitsu H; Wakasugi E; Takahashi M; Yamatani A
J Palliat Med; 2018 May; 21(5):588-591. PubMed ID: 29319397
[TBL] [Abstract][Full Text] [Related]
15. Quality of life in ALS depends on factors other than strength and physical function.
Simmons Z; Bremer BA; Robbins RA; Walsh SM; Fischer S
Neurology; 2000 Aug; 55(3):388-92. PubMed ID: 10932273
[TBL] [Abstract][Full Text] [Related]
16. Measurement of decline of functioning in persons with amyotrophic lateral sclerosis: responsiveness and possible applications of the Functional Independence Measure, Barthel Index, Rehabilitation Activities Profile and Frenchay Activities Index.
De Groot IJ; Post MW; Van Heuveln T; Van Den Berg LH; Lindeman E
Amyotroph Lateral Scler; 2006 Sep; 7(3):167-72. PubMed ID: 16963406
[TBL] [Abstract][Full Text] [Related]
17. How are cognitive impairment, fatigue and signs of depression related to participation in daily life among persons with multiple sclerosis?
Ben Ari Shevil E; Johansson S; Ytterberg C; Bergström J; von Koch L
Disabil Rehabil; 2014; 36(23):2012-8. PubMed ID: 24524439
[TBL] [Abstract][Full Text] [Related]
18. The relationship of rate and pause features to the communicative participation of people living with ALS.
Connaghan KP; Green JR; Eshghi M; Haenssler AE; Scheier ZA; Clark A; Iyer A; Richburg BD; Rowe HP; Okada J; Johnson SA; Onnela JP; Burke KM; Berry JD
Muscle Nerve; 2024 Aug; 70(2):217-225. PubMed ID: 38837773
[TBL] [Abstract][Full Text] [Related]
19. Rates of progression of weight and forced vital capacity as relevant measurement to adapt amyotrophic lateral sclerosis management for patient Result of a French multicentre cohort survey.
Clavelou P; Blanquet M; Peyrol F; Ouchchane L; Gerbaud L
J Neurol Sci; 2013 Aug; 331(1-2):126-31. PubMed ID: 23809193
[TBL] [Abstract][Full Text] [Related]
20. The Amyotrophic Lateral Sclerosis Functional Rating Scale. Assessment of activities of daily living in patients with amyotrophic lateral sclerosis. The ALS CNTF treatment study (ACTS) phase I-II Study Group.
Arch Neurol; 1996 Feb; 53(2):141-7. PubMed ID: 8639063
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
